Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.09 (2.43%)
Spread: 0.04 (1.053%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.71
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

7 Jun 2013 16:15

RNS Number : 6048G
Plant Health Care PLC
07 June 2013
 



PLANT HEALTH CARE PLC

("Plant Health Care" or "the Company")

 

Directorship Change

Plant Health Care appoints James Ede-Golightly as Non-Executive Director

The Board of Plant Health Care is pleased to announce the appointment of Mr. James Ede-Golightly as a non-executive director.

Mr. Ede-Golightly, age 33, has extensive experience as a non-executive on the Boards of small and mid-sized AIM quoted companies with international business interests. In 2012, he was awarded New Chartered Director of the Year by the Institute of Directors.

From 2006 to 2009 Mr. Ede-Golightly was an executive director of ORA Capital Partners Ltd, where he remains a non-executive director. He is a CFA Charterholder and was previously an analyst at Merrill Lynch Investment Managers and Commerzbank.

The Board is very mindful of the need to achieve high standards of corporate governance in a cost effective manner. A key element of this is achieving effective engagement, trust and communication with the shareholder base as a whole. James' connections and experience of our major shareholders, together with his particular experience of smaller AIM quoted companies, makes him a welcome addition to the Board.

Mr. Ede-Golightly has a personal holding of 163,000 shares in the Company (representing 0.23 % of the current issued share capital), and a further beneficial interest in 200,000 shares (0.28% of its share capital) through Fermain Capital Limited.

In addition, Mr. Ede-Golightly has an indirect interest in the Company through ORA Capital Partners Limited and its associate companies, Antisoma plc and Quoram plc. These companies have previously disclosed holdings of 12,095,279 3,377,596 and 844,400 shares in the Company respectively (representing 17.15%, 4.79% and 1.20% of its share capital).

Save for the information disclosed above there is no other information to be disclosed under Rule 17 or Schedule Two, paragraph (g) of the AIM Rules for Companies in relation to Mr James Lawrence Ede-Golightly appointment as a Director of the Company other than as follows:

Current Directorships Past Directorships:

Eland Oil and Gas plc (AIM: ELA) Obtala Resources Ltd (AIM: OBT)

Quoram plc (AIM: QRM) Paragon Diamonds Ltd (AIM: PRG)

ORA Capital Partners Ltd (AIM: ORA) Bendell Enterprises Ltd

ORA (Guernsey) Ltd Grandinex Ltd

East Balkan Properties plc OCS Trading Ltd

Oralian Trading Systems Ltd Equest Investments Balkan Ltd

Fermain Capital Ltd Novum Securities Ltd

Osceola Royalties LLP OCP Investments Ltd

Osceola Production LLP Obtala Resources plc

Obtala Ltd

Ansco Petroleum Ltd

Ansco Petroleum (Eastern) Ltd

ORA Capital Ltd

 

For further information please contact:

 

Plant Health Care plc

Dr. Christopher Richards, Chairman

Tel: +44 (0) 20 7250 1446

Paul Schmidt, Chief Executive Officer

Tel: +1-412-826-5488

Nomura Code Securities

Tel: +44 (0) 20 7776 1200

Clare Terlouw / Chris Golden

Powerscourt

Tel: +44 (0) 20 7250 1446

Paul Durman / Nick Dibden / Sophie Moate

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEDLFBXQFBBBL
Date   Source Headline
22nd Apr 20247:00 amRNSApproval of Harpinαβ in Belgium
16th Apr 20247:00 amRNSPlant Health Care--China Distribution with AMVAC
4th Apr 20247:00 amRNSApproval of PHC68949 in Mexico
4th Mar 20241:55 pmRNSHolding(s) in Company
24th Jan 20244:27 pmRNSHolding(s) in Company
2nd Jan 20247:00 amRNSBrazil approves TEIKKOâ„¢
20th Dec 20237:00 amRNSBoard Changes and Grant of Options
19th Dec 20233:34 pmRNSHolding(s) in Company
30th Nov 20231:45 pmRNSHolding(s) in Company
28th Nov 20233:16 pmRNSHolding(s) in Company
27th Nov 20234:03 pmRNSHolding(s) in Company
27th Nov 20231:27 pmRNSHolding(s) in Company
24th Nov 20234:19 pmRNSDirector/PDMR Shareholding
24th Nov 202310:57 amRNSDirector/PDMR Shareholding
23rd Nov 20232:31 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSChange of Adviser
20th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20236:28 pmRNSPlant Health Care PREtec Product with Agrii UK
28th Sep 20237:00 amRNSNew PREtec Products Announced
27th Sep 20237:00 amRNSUnaudited Interim Results
25th Sep 20237:00 amRNSPREtec Products Submitted for Regulatory Approval
31st Aug 20237:00 amRNSNotice of Results & Investor Presentation
18th Aug 20237:00 amRNSNew Product Regulatory Approval In Brazil
1st Aug 20237:00 amRNSApproval for Sale of Harpin aß Granted in Poland
24th Jul 20237:00 amRNSGrant of Options
12th Jul 202312:27 pmRNSHolding(s) in Company
30th Jun 20235:07 pmRNSNotification of Major Holdings
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.